✦ LIBER ✦
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
✍ Scribed by David Gonzalez-Barcena; Manuel Vadillo-Buenfil; Adolfo Cortez-Morales; Margarita Fuentes-Garcia; Imelda Cardenas-Cornejo; Ana Maria Comaru-Schally; Andrew V. Schally
- Book ID
- 119047603
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 860 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.